Filing Details
- Accession Number:
- 0001415889-23-001588
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-30 16:58:25
- Reporting Period:
- 2023-01-26
- Accepted Time:
- 2023-01-30 16:58:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Transaction Summary
Sold: | 16,000 shares | Avg. Price: $262.12 | Total Value: $4,193,841.14 |
Number of Shares After Transactions: | 130 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-01-26 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-01-26 | 3,642 | $263.99 | 4,488 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-01-26 | 4,292 | $264.38 | 196 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-01-26 | 66 | $266.00 | 130 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-01-27 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-01-27 | 2,380 | $258.93 | 5,750 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-01-27 | 3,701 | $259.71 | 2,049 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-01-27 | 794 | $260.68 | 1,255 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-01-27 | 105 | $261.61 | 1,150 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-01-27 | 1,020 | $262.94 | 130 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2023-01-26 | 8,000 | $0.00 | 8,000 | $113.08 |
Common Stock | Stock Options | Disposition | 2023-01-27 | 8,000 | $0.00 | 8,000 | $113.08 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
528,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
520,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 166 | Indirect | By Spouse |
Common Stock | 644,183 | Indirect | By Trusts |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
- This transaction was executed in multiple trades at prices ranging from $263.165 to $264.155. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $264.17 to $265.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $258.265 to $259.235. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $259.27 to $260.155. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- his transaction was executed in multiple trades at prices ranging from $260.27 to $261.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- his transaction was executed in multiple trades at prices ranging from $261.505 to $261.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- his transaction was executed in multiple trades at prices ranging from $262.61 to $263.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.